Education *CMEJune 10, 2021
It’s Time for a Change: IPC Psoriasis Severity Reclassification (CME)
Psoriasis classification is more than a BSA or PASI score. Listen as Dr. Bruce Strober, Clinical Professor of Dermatology at Yale University, New Haven, CT, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR, discuss the International Psoriasis Council's rationale for changing psoriasis severity classification for treatment decisions and clinical trials.
This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.